References
- Schiffman M, Lamparello N. Uterine-artery embolization or myomectomy for uterine fibroids. N Engl J Med. 2020;383(22):1–9.
- Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512. doi: 10.1111/1471-0528.14640.
- Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi: 10.1067/mob.2003.99.
- Munro MG, Critchley HO, Broder MS, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.
- Puri K, Famuyide AO, Erwin PJ, et al. Submucosal fibroids and the relation to heavy menstrual bleeding and anemia. Am J Obstet Gynecol. 2014;210(1):38.e1–38.e7. doi: 10.1016/j.ajog.2013.09.038.
- Chabbert-Buffet N, Esber N, Bouchard P. Fibroid growth and medical options for treatment. Fertil Steril. 2014;102(3):630–639. doi: 10.1016/j.fertnstert.2014.07.1238.
- Radhika BH, Naik K, Shreelatha S, et al. Case series: pregnancy outcome in patients with uterine fibroids. J Clin Diagn Res. 2015;9(10):QR01–QR04. doi: 10.7860/JCDR/2015/14375.6621.
- Lu N, Wang Y, Su YC, et al. Effects of the distance between small intramural uterine fibroids and the endometrium on the pregnancy outcomes of in vitro fertilization-embryo transfer. Gynecol Obstet Invest. 2015;79(1):62–68. doi: 10.1159/000363236.
- Xu F, Deng L, Zhang L, et al. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta analysis. Int J Hyperthermia. 2021;38(2):24–29. doi: 10.1080/02656736.2021.1933216.
- Loddo A, Djokovic D, Drizi A, et al. Hysteroscopic myomectomy: the guidelines of the International Society for Gynecologic Endoscopy (ISGE). Eur J Obstet Gynecol Reprod Biol. 2022;268:121–128.
- Zheng AQ, Chen JY, Xiao ZB, et al. Sacral injury and influencing factors after ultrasonic ablation of uterine fibroids ≤30 mm from the sacrum. Diagn Interv Radiol. 2023;29(1):195–201. doi: 10.5152/dir.2022.21407.
- Xie B, Zhang C, Xiong C, et al. High intensity high intensity focused ultrasoundablation for submucosal fibroids: a comparison between type I and type II. Int J Hyperthermia. 2015;31(6):593–599. doi: 10.3109/02656736.2015.1046406.
- Wang W, Wang Y, Wang T, et al. Safety and efficacy of US-guided high-intensity high intensity focused ultrasound for treatment of submucosal fibroids. Eur Radiol. 2012;22(11):2553–2558. doi: 10.1007/s00330-012-2517-z.
- Liao P, Jiang J, Zeng YH, et al. Comparison of outcomes of hysteroscopic myomectomy of type 2 submucous fibroids greater than 4 cm in diameter via pretreatment with HIFU or GnRH-a. Int J Hyperthermia. 2021;38(1):183–188. doi: 10.1080/02656736.2021.1874546.
- Tingting L, Yuchun H, Jia H, et al. Preliminary clinical study on rapid reduction of type II.∼III. (FIGO) uterine fibroids by focused ultrasound ablation therapy. Cancer Prev Treat. 2021;34(8):743–751.
- Lei T, Guo X, Gong C, et al. High-intensity focused ultrasound ablation in the treatment of recurrent ovary cancer and metastatic pelvic tumors: a feasibility study. Int J Hyperthermia. 2021;38(1):282–287. doi: 10.1080/02656736.2021.1889698.
- Sacks D, McClenny TE, Cardella JF, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199–S202. doi: 10.1097/01.rvi.0000094584.83406.3e.
- Clavien PA, Barkun J, Oliveira MLD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–196. doi: 10.1097/SLA.0b013e3181b13ca2.
- Spies J. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290–300. doi: 10.1016/S0029-7844(01)01702-1.
- Gudmundsdottir BR, Hjaltalin EF, Bragadottir G, et al. Quantification of menstrual flow by weighing protective pads in women with normal, decreased or increased menstruation. Acta Obstet Gynecol Scand. 2009;88(3):275–279. doi: 10.1080/00016340802673162.
- Piecak K, Milart P. Hysteroscopic myomectomy. Prz Menopauzalny. 2017;16(4):126–128. doi: 10.5114/pm.2017.72757.
- Mazzon I, Favilli A, Grasso M, et al. Is cold loop hysteroscopic myomectomy a safe and effective technique for the treatment of submucous myomas with intramural development? A series of 1434 surgical procedures. J Minim Invasive Gynecol. 2015;22(5):792–798. doi: 10.1016/j.jmig.2015.03.004.
- Laganà AS, Alonso Pacheco L, Tinelli A, et al. Management of asymptomatic submucous myomas in women of reproductive age: a consensus statement from the global congress on hysteroscopy scientific committee. J Minim Invasive Gynecol. 2019;26(3):381–383. doi: 10.1016/j.jmig.2018.06.020.
- Ricci G, Scrimin F, Sartore A, et al. Characteristics of submucous myomas and the risk of anemia. Medicina. 2022;58(11). doi: 10.3390/medicina58111652.
- Shengpeng Z, Yuting S, Luping Z, et al. Clinical efficacy analysis of hysteroscopic type II submucosal large fibroid resection. Chin Med J. 2022;57(12):3.